"The Future of Peptide and Oligonucleotide CDMO Market: 12.5%...

أضاف وظيفة جديدة Bailar

2026-02-27 10:41:14 - ترجمة

"The Future of Peptide and Oligonucleotide CDMO Market: 12.5% CAGR and Emerging Opportunities"

Regulatory pressures are another factor influencing the peptide and oligonucleotide CDMO market. Stringent quality standards imposed by regulatory agencies like the FDA and EMA require CDMOs to maintain high production standards and ensure the safety and efficacy of these therapeutics. This compliance with international standards is a key requirement for CDMOs hoping to serve global...

0 التعليقات 0 المشاركات 46 مشاهدة 0 معاينة